Home / Health & Education / Health
Second human trials of Covid-19 vaccine expected to start this month
Anh Kiet - Tran Thao 08:44, 2021/01/05
If all three phases show good results, the second made-in-Vietnam Covid-19 vaccine will be available in the market as soon as late 2021.

The human trial of Vietnam’s second Covid-19 vaccine is expected to begin this month, which is two months earlier than planned.

The Institute of Vaccines and Medical Biologicals (IVAC), based in the souther province of Khanh Hoa, has requested the Ministry of Health’s permission for the human trials of its Covid-19 vaccine this month.

 The second made-in-Vietnam Covid-19 vaccine will be available in the market as soon as late 2021. Photo: Kinhtedothi.vn

The IVAC said the request was made following the testing on animals like hamsters, mice, and rabbits, which has shown that the candidate vaccine is safe and creates high immune response.

If permitted, this will be the second Vietnamese vaccine in clinical trials on humans, after Nanocovax of the Nanogen Pharmaceutical Biotechnology JSC, which started the first phase of human trials in mid-December 2020.

IVAC Director Duong Huu Thai said the institute’s research on a Covi-19 vaccine began in May, aiming to successfully produce a vaccine and complete three phases of clinical trials in 18 months.

The first phase will begin in January and conclude in April. If all three phases show good results, the vaccine will be mass produced in late 2021.

“Initial results are relatively good,” Mr. Thai said, noting that the first phase of testing will last for about two months and finish in April.

During the first phase, 125 volunteers divided into three groups will receive different doses.

The volunteers must be healthy people aged from 18 to 59 and who are free from any underlying condition. They also need to meet several other requirements.

Each volunteer will receive two shots with a 28-day interval.

The IVAC is set to coordinate with the National Institute of Hygiene and Epidemiology (NIHE) and the Hanoi Medical University to conduct clinical trials.

Apart from the IVAC’s vaccine and Nanocovax, Vietnam also has some other Covid-19 candidate vaccines in development.

Vietnam on December 4 recorded 1,497 Covid-19 cases and 1,339 recoveries. The number of deaths related to the disease is still kept at 35.

TAG: Made-in-Vietnam Covid-19 vaccine human
Other news
18:07, 2023/05/29
Vietnam to establish warehouses for orphan drugs
Vietnam's legal framework for orphan drugs is in place to enable hospitals to have storage plans.
15:27, 2023/05/23
Vietnam aims to be ASEAN's vaccine production hub
Through international experience and collaboration among key stakeholders, Vietnam aims to become a regional leader in vaccine production.
18:12, 2023/05/15
Vietnam secures Covid-19 vaccine supply for expanded immunization program
The national program ensuring the supply of Covid-19 vaccines will focus on educating and training human resources.
17:34, 2023/05/11
Global Fund pledges support for Vietnam to end AIDS, TB and malaria
The Global Fund continues to support Vietnam to promote its achievements, mobilize resources and share experiences in the fight against AIDS, TB and malaria.
16:48, 2023/05/10
It’s high time to scale up HPV vaccination
Vietnam may be able to eradicate cervical cancer over the next 30 years if HPV vaccination rates are increased to reach 90% of teenage girls and 70% of females undergoing HPV-based screening.
01:51, 2023/05/10
Vietnam – exceptional example of fighting against HIV/AIDS: PEPFAR
Today, more than 70% of the estimated 240,000 people living with HIV in Vietnam receive antiretroviral (ARV) drugs through Social Health Insurance, funded by domestic resources.